Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.27% |
| 2 | Technology | 12.59% |
| 3 | Healthcare | 10.49% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Barings BDC
BBDC
$965M
| $1.01M | ﹤0.01% |
70,847
+24,313
| +52% | +$367K |
|
2502
Theriva Biologics
TOVX
$10.1M
| $1.01M | ﹤0.01% |
124
-23
| -16% | -$133K |
|
2503
CALL
Integra LifeSciences
IART
$1.34B
| $1.01M | ﹤0.01% |
+20,000
| New | +$1.03M |
|
2504
iShares Russell 1000 Growth ETF
IWF
$128B
| $998K | ﹤0.01% |
31,912
-1,820
| -5% | -$55.7K |
|
|
CVON
2505
DELISTED
ConvergeOne Holdings, Inc. Class A Common Stock
CVON
| $998K | ﹤0.01% |
102,326
-2,600
| -2% | -$25.3K |
|
2506
CALL
Illumina
ILMN
$28.4B
| $996K | ﹤0.01% |
+5,140
| New | +$957K |
|
|
2507
PUT
Illumina
ILMN
$28.4B
| $996K | ﹤0.01% |
5,140
+2,056
| +67% | +$383K |
|
|
NXEO
2508
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $995K | ﹤0.01% |
+136,353
| New | +$1.04M |
|
2509
Alico
ALCO
$283M
| $993K | ﹤0.01% |
+29,084
| New | +$924K |
|
|
Y
2510
DELISTED
Alleghany Corp
Y
| $992K | ﹤0.01% |
1,790
-653
| -27% | -$381K |
|
2511
Unifirst Corp
UNF
$5.25B
| $989K | ﹤0.01% |
6,526
-21,283
| -77% | -$3.01M |
|
|
OMED
2512
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $988K | ﹤0.01% |
218,490
-64,175
| -23% | -$260K |
|
|
JONE
2513
DELISTED
Jones Energy, Inc.
JONE
| $986K | ﹤0.01% |
25,684
+14,935
| +139% | +$399K |
|
2514
RCI Hospitality Holdings
RICK
$215M
| $985K | ﹤0.01% |
+39,786
| New | +$949K |
|
|
SPNE
2515
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $985K | ﹤0.01% |
87,831
-98,733
| -53% | -$1.14M |
|
|
HLTH
2516
DELISTED
Nobilis Health Corp.
HLTH
| $985K | ﹤0.01% |
656,787
-70,031
| -10% | -$111K |
|
|
AKTS
2517
DELISTED
Akoustis Technologies Inc
AKTS
| $983K | ﹤0.01% |
150,714
+46,944
| +45% | +$327K |
|
|
MCBC
2518
DELISTED
Macatawa Bank Corp
MCBC
| $981K | ﹤0.01% |
95,639
-40,591
| -30% | -$386K |
|
|
FPO
2519
DELISTED
First Potomac Realty Trust
FPO
| $981K | ﹤0.01% |
+88,048
| New | +$980K |
|
2520
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
| $979K | ﹤0.01% |
30,264
-51,688
| -63% | -$1.62M |
|
|
GOGL
2521
DELISTED
Golden Ocean Group
GOGL
| $978K | ﹤0.01% |
124,690
-2,020
| -2% | -$16.2K |
|
2522
AeroVironment
AVAV
$9.45B
| $976K | ﹤0.01% |
+18,026
| New | +$767K |
|
2523
Vanguard Energy ETF
VDE
$9.74B
| $976K | ﹤0.01% |
10,434
+7,661
| +276% | +$680K |
|
2524
Globus Medical
GMED
$11.2B
| $975K | ﹤0.01% |
32,813
-4,020
| -11% | -$123K |
|
|
STDY
2525
DELISTED
SteadyMed Ltd
STDY
| $972K | ﹤0.01% |
290,000
+41,207
| +17% | +$219K |
|
Similar funds
Millennium Management's Q3 2017 Portfolio in Review
As of Q3 2017, Millennium Management held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Millennium Management deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Millennium Management's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Millennium Management added most to Salesforce in Q3 2017, an estimated $208M increase.
- Millennium Management's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Millennium Management fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Millennium Management's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Millennium Management opened 794 new positions and closed 737 in Q3 2017.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.